Hetero announces interim clinical results from Phase III clinical trials of Molnupiravir conducted in India
Jul 09, 2021
Hyderabad (Telangana) [India], July 9 : Hetero, a globally renowned vertically integrated pharmaceutical organization, on Friday announced the interim clinical results from Phase III...